Bio Rad Laboratories Inc (NYSE:BIO)
| 303.85 Delayed Data As of Dec 08 |  -6.33 / -2.04%Today’s Change | 261.59 Today|||52-Week Range 509.62 | -27.74% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 457.5M | 456.3M | 383.8M | 431.6M | |
| Short Term Investment Cash | 48.5M | -935.0K | -72.4M | 49.2M | ||
| Cash & Short Term Investments | 790.5M | 844.0M | 760.5M | 850.5M | ||
| Receivables | Receivables | 391.5M | 372.3M | 464.8M | 392.4M | |
| Inventories | Inventories | 490.2M | 525.0M | 594.8M | 583.8M | |
| Current Assets | Prepaid Expenses | 94.4M | 91.0M | 146.1M | 187.2M | |
| Other Current Assets | 11.0M | 12.2M | 10.3M | 9.5M | ||
| Current Assets | 1.8B | 1.8B | 2.0B | 2.0B | ||
| Total Assets | Property, Plant and Equipment - Gross | 1.1B | 1.2B | 1.3B | 1.3B | |
| Depreciation | -679.4M | -738.8M | -811.7M | -818.1M | ||
| Intangible Assets | 710.0M | 638.7M | 680.2M | 352.9M | ||
| Other Assets | 776.4M | 686.6M | 775.1M | 420.7M | ||
| Total Assets | 3.7B | 3.9B | 4.3B | 5.6B | ||
| Liabilities | Accounts Payable | 122.4M | 133.1M | 135.2M | 122.5M | |
| Short Term Debt | 298.0K | 334.0K | 420.0K | 493.0K | ||
| Other Current Liabilities | 131.5M | 146.4M | 155.5M | 156.8M | ||
| Other Liabilities | 441.4M | 471.3M | 502.7M | 450.8M | ||
| Total Liabilities | Long Term Debt | 435.7M | 434.2M | 434.6M | 438.9M | |
| Deferred Taxes | -233.5M | -222.9M | -222.2M | -553.2M | ||
| Other Liabilities | 110.5M | 111.3M | 169.3M | 142.6M | ||
| Total Liabilities | 1.2B | 1.3B | 1.3B | 1.6B | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 2.5B | 2.6B | 2.9B | 4.0B | ||
| Total Shareholder Equity | 2.5B | 2.6B | 2.9B | 4.0B | ||
| Share Information | Common Shares Outstanding | 29.4M | 29.6M | 29.8M | 29.8M | |
| Addtl. Info. | No data currently available for this section. | |||||
